Document is current
Any future updates will be listed below
-
Authors
Hagerling, Catharina
Owyong, Mark
Sitarama, Vaishnavi
Wang, Chih-Yang
Lin, Charlene
van den Bijgaart, Renske J. E.
Koopman, Charlotte D.
Brenot, Audrey
Nanjaraj, Ankitha
Wärnberg, Fredrik
Jirström, Karin
Klein, Ophir D.
Werb, Zena
Plaks, Vicki
-
Funding
Funding for this research was provided by:
Division of Cancer Epidemiology and Genetics, National Cancer Institute (CA057621, CA180039, CA199315, CA190851)
National Institute of Dental and Craniofacial Research (R35_DE026602)
Tegger Foundation
Wenner-Gren Foundation
Sweden-America Foundation
Swedish Society of Medicine
Svenska Sällskapet för Medicinsk Forskning
Ministry of Science and Technology, Taiwan (MOST104-2917-I-006-002)
Cancer League
California Breast Cancer Research Program (23IB–001)
- License Information
-
More Information
Article History
Received: 4 November 2019
Accepted: 20 May 2020
First Online: 10 June 2020
Ethics approval and consent to participate
: Written ethical permit for the DCIS TMA was approved from the ethical committee at Uppsala University Hospital. Written ethical permit for the BC TMA was approved from the ethical committee at Lund University. Informed consent is deemed unnecessary according to national regulations; ethical committees at Uppsala University Hospital and Lund University. All cell lines used in our study does not require any ethical approval. Animal experiments in our study were performed according to the Institutional Animal Care and Use Committee (IACUC) guidelines. All procedures have written approval through IACUC by The University of California, San Francisco and Washington University.
: Written consent is provided by all the authors and participants for use of individual details and images.
: The authors declare that they have no competing interests.
